Stock listing

URGN Stock Price, News, Filings & Events — Urogen Pharma Ltd.

Selected listing: URGN · NASDAQ · USD · US

This page tracks Urogen Pharma Ltd.'s URGN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following URGN:NASDAQ. URGN:NASDAQ is the stock-level entry point for investors researching Urogen Pharma Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Urogen Pharma Ltd. is a public company listed under the ticker URGN, operating in the American market. The company has a market capitalization of approximately $1.96 billion. Urogen focuses on developing innovative therapies for urological diseases, aiming to improve patient outcomes.